In vitro synergistic effects of some novel Cu(II) complexes in combination with epirubicin and mitomycin C against HeLa-S3 cervical cancer cell line

被引:7
作者
Geromichalos, GD [1 ]
Katsoulos, GA [1 ]
Hadjikostas, CC [1 ]
Kortsaris, AH [1 ]
Kyriakidis, DA [1 ]
机构
[1] ARISTOTELIAN UNIV THESSALONIKI, DEPT CHEM, GR-54006 THESSALONIKI, GREECE
关键词
Cu(II) complexes; cytotoxicity assay; epirubicin; HeLa-S3; cells; mitomycin C; synergism; XTT tetrazolium salt;
D O I
10.1097/00001813-199606000-00012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The in vitro predictive chemosensitivity of a HeLa-S3 human cervical cancer cell line to a new series of Cu(ll) complexes as well as their combination with several chemotherapeutic drugs was determined. Antiproliferative activity was evaluated by the XTT assay, Among all tested drugs, HeLa-S3 cells were especially sensitive to epirubicin (EPR) or mitomycin C (MMC) antitumor agents, The combination of EPR or MMC with the complexes resulted in a pronounced synergistic amplification of their antiproliferative effect, This marked synergism was observed in all drug combinations.
引用
收藏
页码:469 / 475
页数:7
相关论文
共 24 条
[1]   CRITERIA FOR ANALYZING INTERACTIONS BETWEEN BIOLOGICALLY-ACTIVE AGENTS [J].
BERENBAUM, MC .
ADVANCES IN CANCER RESEARCH, 1981, 35 :269-335
[2]   SYNERGISTIC INTERACTION OF KETHOXAL BIS(THIOSEMICARBAZONE) AND CUPRIC IONS IN SARCOMA 180 [J].
BOOTH, BA ;
SARTOREL.AC .
NATURE, 1966, 210 (5031) :104-&
[3]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[4]  
CRIM JA, 1967, CANCER RES, V27, P1278
[5]  
FREI E, 1972, CANCER RES, V32, P2593
[6]  
FRESHNEY RI, 1986, ANN CELL CULTURE PRA, P213
[7]  
GAREWAL HS, 1986, J NATL CANCER I, V77, P1039
[8]  
HADJIKOSTAS CC, 1966, IN PRESS STRUCT CHEM
[9]   IMPROVED SHORT-TERM AND LONG-TERM XTT-BASED COLORIMETRIC CELLULAR CYTOTOXICITY ASSAY FOR MELANOMA AND OTHER TUMOR-CELLS [J].
JOST, LM ;
KIRKWOOD, JM ;
WHITESIDE, TL .
JOURNAL OF IMMUNOLOGICAL METHODS, 1992, 147 (02) :153-165
[10]  
KANO Y, 1988, CANCER RES, V48, P351